Dialysis: The Daily Lives of 88,000 People and an Unmet Curve

In 2022, 88,555 people in Taiwan were receiving dialysis, with 12,459 new cases and 13,172 deaths annually; the incidence rate remains among the highest globally. This article uses the "Taiwan Kidney Disease Annual Report" to analyze prevalence, a 55.1% five-year survival rate, peritoneal dialysis at 7.5%, transplant rates, and policy goals for home dialysis.

Dialysis is one of the most expensive treatments under Taiwan's National Health Insurance (NHI), yet it is also one of the most routine. In 2022, the total medical points for patients with End-Stage Renal Disease (ESRD) reached 70.26 billion points, accounting for approximately 8.6% to 8.9% of the total NHI expenditure that year. 1

When distributed per person, this amounts to over 71,100 points per month. Looking only at the numbers, it is easy to conclude that the cost is "too high" or "too expensive"; however, when broken down, one sees a path stretching from prevention to dialysis, from hemodialysis to peritoneal dialysis, and from dialysis to transplantation—a path where several segments remain disconnected.

71,100 Points Per Month

In 2022, the average total medical points for ESRD patients was 71,100 points per person per month. Among them, hemodialysis patients averaged 75,000 points, while peritoneal dialysis patients averaged 55,500 points; the dialysis itself accounted for 45,900 points, while care for non-dialysis comorbidities and complications accounted for 25,200 points. 1

These figures illustrate a frequently overlooked fact: the cost of dialysis is not just about the act of "washing." More than one-third of the expenditure goes toward managing cardiovascular issues, infections, anemia, and other comorbidities, as most ESRD patients also live with hypertension, diabetes, and heart disease. 1

From the perspective of total NHI expenditure, hemodialysis medical points accounted for 5.1% of overall costs in 2022, while outpatient and emergency dialysis points accounted for 7.7% of outpatient/emergency expenditures. The annual medical points used by ESRD patients grew from 53.49 billion points in 2014 to 70.26 billion points in 2022, while their share of total expenditure remained relatively stable between 8.6% and 8.9%. 1

Three Numbers: Incidence, Prevalence, and Mortality

In 2022, Taiwan saw 12,459 new dialysis cases, a prevalence of 88,555, and 13,172 deaths. The prevalence figure decreased slightly from 89,822 in 2021, but the number of deaths rose steadily from 9,752 in 2018 to 13,172 in 2022. 1

The incidence rate is 536 per million people, higher than the 431 per million recorded in 2011; after adjusting for the WHO standard age structure, the standardized incidence rate for 2022 was 290 per million. The prevalence rate dropped from 3,843 per million in 2021 to 3,806 per million in 2022. 1

There is also a clear age signal regarding mortality. The dialysis mortality rate is 14.8 per 100 dialysis-person-years; for those aged 75 and above, it is 27.1, whereas for those aged 20 to 39, it is only 5.0. The average age of prevalent dialysis patients is 65.7, while the average age of deceased patients is 73.6. Among prevalent patients, 49.0% have been on dialysis for five years or more, compared to 51.2% among deceased patients. 1

Three Key Figures for Dialysis in Taiwan (2022)
ValueDescription
New Dialysis Cases
12,459 people
Dialysis Prevalence
Down from 89,822 in 2021
Dialysis Mortality
13,172 people
Three Key Figures for Dialysis in Taiwan (2022)
ItemValueDescription
New Dialysis Cases12,459 peopleIncidence: 536 per million
Dialysis Prevalence88,555 peopleDown from 89,822 in 2021
Dialysis Mortality13,172 people14.8 per 100 dialysis-person-years

Source: Summary of "2024 Taiwan Kidney Disease Annual Report"

Diabetes, Aging, and the "Global Lead"

Among new dialysis patients, 46.1% had diabetes as their primary diagnosis; among prevalent patients, 48.4% had diabetes in the previous year. 1

The average age at the start of dialysis is 67.9. Changes in the prevalence structure further illustrate the direction of this curve: the number of prevalent dialysis patients under age 65 is decreasing, while those over 65 are increasing. 1

The introduction of the annual report describes Taiwan's international standing quite directly: "Although the incidence and prevalence rates of dialysis in Taiwan have shown a trend of gradual stabilization or slight decline in recent years, in terms of absolute indicators, they still lead the world by a wide margin." 1 A 2018 fiscal evaluation report from the Legislative Yuan's Budget Center also described the same situation, stating that "prevalence and incidence rates are the highest in the world." 2

A caveat is necessary here: part of the reason for high incidence and prevalence rates may stem from Taiwan's dialysis accessibility and NHI coverage, which allows those in need to actually access treatment rather than only those who can afford it. Reading a high prevalence rate simply as "too much dialysis" misses this layer of context.

An Unmet Curve

What is truly worth examining is the year prior to entering dialysis. From 2018 to 2022, the rate of new dialysis patients who had visited an emergency room in the year preceding dialysis was between 72.6% and 75.2%, and the rate of those who had entered an intensive care unit (ICU) was between 31.8% and 33.5%. 1

In other words, three-quarters of patients visited an emergency room in the year before starting dialysis, and about one-third had been in an ICU. This does not necessarily mean a breakdown in care, but it indicates that the final stages of the disease are often discovered in emergency rooms and hospital wards.

The NHI Administration's Pre-ESRD program aims to shift this curve forward. The rate of new dialysis patients participating in the program in the year prior to dialysis increased from 63.2% in 2018 to 67.7% in 2022; however, in 2022, the average eGFR value for new patients when they began dialysis was only 6.0 ml/min/1.73m². 1

Another easily overlooked indicator is the rate at which first-time hemodialysis patients completed vascular access (fistula or graft) construction within one year prior to dialysis and up to three months after starting; this dropped from 69.5% in 2014 to 59.2% in 2022. 1 This means more people are starting dialysis without prepared vascular access, often requiring the placement of temporary catheters.

Hemodialysis vs. Peritoneal Dialysis: 7.5% and 18%

Dialysis in Taiwan is primarily hemodialysis. In 2022, the prevalence rate for peritoneal dialysis was 7.5%, while for new patients it was 9.5%; if the scope is narrowed to new patients under age 60 without diabetes, the peritoneal dialysis rate rises to 23.8%. 1

The clinical outcomes of peritoneal dialysis are quite good. Between 2013 and 2017, the 1-year and 5-year cumulative survival rates for new peritoneal dialysis patients were 98.0% and 68.7%, respectively, compared to 89.1% and 53.6% for hemodialysis. It is also less expensive, at 55,500 points per person per month versus 75,000 points. 1

The trade-off is that the responsibility for care shifts home. Peritoneal dialysis requires daily operation, home space, and infection control; in 2022, there were 1,217 reported cases of peritonitis, or 1.5 cases per 100 person-months—this is the risk indicator for this path. 1

Policy direction was provided in December 2025: with nearly 97,000 people on dialysis in Taiwan and home peritoneal dialysis accounting for only 7%, President Lai Ching-te proposed a goal of reaching 18% for home dialysis by 2035. In the same month, the Taiwan Society of Nephrology released a new "Taiwan Home Dialysis White Paper." 3 The annual report's introduction reminds us that while the budget for peritoneal dialysis has increased significantly in recent years, its proportion of total spending has not risen significantly, pointing to issues in patient education, shared decision-making between doctors and patients, and care teams. 1

5-Year Cumulative Survival Rate of New Dialysis Patients (2013–2017) (%)
Peritoneal Dialysis
68.7 1-year survival: 98.0%
All Dialysis
55.1 1-year: 90.0%, 3-year: 70.8%
Hemodialysis
53.6 1-year: 89.1%

Source: Summary of "2024 Taiwan Kidney Disease Annual Report" and International Comparison Section

Transplantation: 295 Cases and 88 Donors per Year

The other alternative to dialysis is transplantation, but the volume in Taiwan has remained very low. In 2022, there were 295 kidney transplants within the country; the transplant rate fell from 17.2 per million people in 2019 to 12.7 per million in 2022. In the same year, there were only 88 deceased kidney donors. 1

Domestic transplants are primarily deceased donor kidneys, accounting for over 50% of cases; patients wait an average of 4.9 years from starting dialysis to receiving a transplant, with an average age of 50.5 at the time of transplantation. 1

Transplantation offers the best outcomes of all options. Between 2012 and 2017, the 1-year, 3-year, and 5-year cumulative survival rates for domestic transplant patients were 96.1%, 93.4%, and 89.0%, respectively; the rate of patients surviving 5 years post-transplant without returning to long-term dialysis was 84.3%. 1

Comparing these three figures—295 transplants per year, 88 deceased donors, and 88,555 people currently on dialysis—reveals where the weight of ESRD care in Taiwan is concentrated.

Quality Is Not Just About Volume

The 1-year, 3-year, and 5-year cumulative survival rates for new dialysis patients between 2013 and 2017 were 90.0%, 70.8%, and 55.1%, respectively; the 5-year survival rate is higher than those in Europe (41.4%), the US (42.0%), and Canada (41.7%). 1

The scale of medical utilization is also significant. In 2022, ESRD patients accounted for 87,002 hospitalizations and 144,303 emergency room visits; the hospitalization rate was 982 per 1,000 dialysis patients. There were 9,230 deaths within one month of discharge, accounting for 20.2% of that year's hospitalizations. 1

The other side of end-stage care is palliative care. The number of dialysis patients who received inpatient palliative care increased from 1,000 in 2018 to 1,833 in 2022, with the usage rate rising from 12.9% to 17.4%. 1 The significance of this figure is that more people are passing away under the premise that "this is the final stage," rather than cycling repeatedly between the emergency room and the ICU.

Closing the Gap in Prevention

The annual report's introduction focuses on two points: "the importance of chronic kidney disease prevention" and the fact that the proportion of peritoneal dialysis "has not yet seen a significant increase." 1

Reading through the entire dataset, the gap is not in total volume. While absolute incidence and prevalence rates are high, care outcomes (55.1% five-year survival) are not poor compared to international benchmarks; what has truly not been "connected" are the emergency room and ICU visits in the year before dialysis, the declining rate of vascular access construction, the distance between the 7.5% peritoneal dialysis rate and the 18% policy goal, and the gap between 295 annual transplants and 88,555 people on dialysis. 13

These gaps do not require new slogans; they simply require that Pre-ESRD enrollment, vascular access preparation, peritoneal dialysis education, and organ donation promotion each reach the standards originally designed for them.

Further Reading:

References

  1. 2024 Taiwan Kidney Disease Annual Report (National Health Research Institutes, Taiwan Society of Nephrology) — Summary and chapters covering 2022: 12,459 new dialysis cases, 88,555 prevalence, 13,172 deaths; incidence 536/prevalence 3,806 (per million); 55.1% five-year cumulative survival; 7.5% peritoneal dialysis share; 295 kidney transplants and 88 deceased donors; total medical points of 70.26 billion, accounting for 8.6%–8.9% of NHI expenditure.↩2345678910111213141516171819202122232425
  2. 107th Fiscal Year Unit Settlement Evaluation Report for Ministry of Health and Welfare Officials (Legislative Yuan Budget Center) — Audit text describes the ESRD situation as "the number of kidney disease patients in our country is growing year by year, and the prevalence and incidence rates are the highest in the world," requesting a review of prevention effectiveness.↩
  3. Dialysis Population Nears 100,000; Home Dialysis Target to Reach 18% by 2035: Shih Chung-liang Reveals Three Major Considerations (Economic Daily News, 2025-12-05) — Reports on the nearly 97,000 dialysis population in Taiwan, home peritoneal dialysis at only 7%, President Lai Ching-te's goal of 18% home dialysis by 2035, and the release of the new "Taiwan Home Dialysis White Paper" by the Taiwan Society of Nephrology.↩2
About this article This article was collaboratively written with AI assistance and community review.
Tags
dialysis peritoneal dialysis chronic kidney disease National Health Insurance healthcare peritoneal dialysis
Share

Further Reading

You might also like

Lifestyle Evolving · Awaiting fact-check

Diabetes: 2.16 Million People, and the One-Third Who Are Not Caught by the Net

According to 2024 NHI statistics, Taiwan has approximately 2.16 million patients with hyperglycemia; of these, 1.77 million meet the criteria for diabetes care programs, but only 1.137 million actually receive care (a 64.0% rate). While regional hospitals reach 70.8%, primary clinics manage only 53.5%. This article analyzes NHI monitoring reports regarding care rates, hospitalization rates, and the 2026 integrated planning, explaining why one-third of eligible patients remain outside the care network and its link to dialysis.

閱讀全文
Lifestyle Evolving · Awaiting fact-check

Organ Donation: 11,550 Waiting, Only 403 Cases in Ten Months

As of late October 2026, 11,550 people in Taiwan are waiting for organ transplants, while only 403 donations were recorded in the first ten months of the year; on average, 3.3 people die daily waiting for organs. Although Taiwan was the first Asian nation to legalize organ donation and transplantation in 1987, the donation rate remains at just 4.87 per million people. Using official monthly reports and frontline interviews, this article examines the four critical links: the donation curve, family consent, living donation, and Donation after Circulatory Death (DCD).

閱讀全文
Lifestyle Evolving · Awaiting fact-check

Palliative Care and Patient Autonomy: World Third Place Ranking, and a 0.5% Signing Rate

In 2023, Taiwan's palliative care utilization rate in the year before death was 30.9%, comparable to the U.S. rate of 30.3%; the 2025 Global Palliative Care Map ranked Taiwan third worldwide and first in Asia. Yet as of end-2024, cumulative advance palliative care directives totaled 1.03 million (5.2% of adults), while advance medical decisions numbered only ~94,000 (0.5%), with 87,835 new directives signed in 2024. This article uses the official annual report to break down two laws, 581 service institutions, 279 counseling institutions, 871 palliative beds, and the gap between concentration in the six special municipalities and low rates in outlying islands.

閱讀全文
Society Evolving · Awaiting fact-check

Mental Health and Suicide Prevention: 3,951 People, and That Curve Returning to the Top Ten

In 2024, Taiwan saw 4,062 suicide deaths with a standardized mortality rate of 13.4 per 100,000, the highest since 2020; suicide returned to the top ten causes of death for the first time in 14 years.

閱讀全文